Streetbeat News

Equity Actions

ITOS

Iteos Therapeutics has announced a registered direct offering of 5.7 million shares of its common stock, priced at $17.499 per share, aiming to raise $120 million. This move is part of the company's efforts to secure additional funding.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 12:27 pm

SMSI

Smith Micro Software, Inc. has announced a follow-on offering valued at $4.1 million. This move is aimed at raising additional capital, potentially for expansion, debt reduction, or other corporate purposes. The specifics of how the funds will be used were not disclosed.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 12:18 pm

BOC

Boston Omaha Corporation announced the departure of Co-CEO and Co-Chair Alex Rozek, effective May 9, 2024. Adam Peterson will continue as the sole Chair and CEO, leading the diversified company into its next phase.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 12:08 pm

BPOP

Popular, Inc. has appointed Javier Ferrer as its new President and Chief Operating Officer (COO). This strategic move could signal a new direction or operational strategy for the company, potentially impacting its performance and stock price.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 12:03 pm

BRX

James M. Taylor Jr. is set to return as CEO and President of Brixmor Property Group Inc. (BRX) on May 20, 2024, after a medical leave. Brian T. Finnegan will revert to his role as Senior EVP and COO.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 12:01 pm

CRL

Charles River (NYSE:CRL) has seen varied analyst ratings over the past three months, with a recent shift towards more positive evaluations. The average 12-month price target for CRL has increased by 6.93% to $273.29, reflecting a positive outlook from analysts. Key financial indicators show Charles River facing challenges in revenue growth and debt management, but excelling in net margin, ROE, and ROA.

Portfolio Pulse from Benzinga Insights

May 10, 2024 | 12:00 pm

FWBI

First Wave BioPharma, Inc. (FWBI) announced a registered direct offering of 366,000 shares at $2.95/share, alongside a private placement of warrants for up to 732,000 shares at $2.70/share, with Roth Capital Partners as the placement agent.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 12:00 pm

ALTM

Arcadium Lithium plc (NYSE:ALTM) has applied to cease being a reporting issuer in various Canadian provinces, aiming to streamline its regulatory obligations.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 11:21 am

GEN

Gen Digital's shares surged following the announcement of Q4 earnings surpassing expectations and the initiation of a $3 billion share repurchase program.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 11:21 am

PCRX

Pacira BioSciences announced the pricing of $250 million aggregate principal amount of 2.125% convertible senior notes due 2029. This financial move could impact the company's stock in the short term due to the potential dilution of shares and the interest payment obligations.

Portfolio Pulse from Benzinga Newsdesk

May 10, 2024 | 11:12 am